Profiling of chromosomal changes in potentially malignant and malignant oral mucosal lesions from South and South-East Asia using array-comparative genomic hybridization

Cancer Genomics and Proteomics

Volumn 11, Issue 3, 2014, Pages 127-140

  Lunde, Mai Lill Suhr ^a   Roman, Eric ^a   Warnakulasuriya, Saman ^b   Mehrotra, Ravi ^c   Laranne, Jussi ^d   Vasstrand, Endre N ^a   Ibrahim, Salah O ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c MLN MEDICAL COLLEGE   (India)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Array CGH; Betel quid; Oral squamous cell carcinoma; Oral submucous fibrosis; S100A14 SNPs

Indexed keywords

ANGIOPOIETIN 1; BRCA1 PROTEIN; CASPASE 4; CASPASE 5; CAVEOLIN 1; CD70 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; COLONY STIMULATING FACTOR RECEPTOR; EPHRIN RECEPTOR A2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MATRIX METALLOPROTEINASE 15; MICROFIBRILLAR ASSOCIATED PROTEIN 2; NOTCH4 RECEPTOR; PARAFFIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN CDC42; PROTEIN KINASE C ALPHA; PROTEIN MAD2; PROTEIN P53; PROTEIN S 100; PROTEIN S 100 A 14; RAC1 PROTEIN; S 100 A1 PROTEIN; S 100 A2 PROTEIN; SUCCINATE DEHYDROGENASE COMPLEX SUBUNIT B PROTEIN; TFNSF14 PROTEIN; TNFSF9 PROTEIN; UNCLASSIFIED DRUG; WNT1 PROTEIN;

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; MUTATION; ORAL MUCOSAL DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ADOLESCENT; ASIA; CLUSTER ANALYSIS; GENETICS; METABOLISM; MIDDLE AGED; MOUTH DISEASE; MOUTH TUMOR; PATHOLOGY; PRECANCER; RISK FACTOR; SQUAMOUS CELL CARCINOMA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASIA; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; ORAL SUBMUCOUS FIBROSIS; PRECANCEROUS CONDITIONS; RISK FACTORS; YOUNG ADULT;

EID: 84903558488     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Cancela MDC, Voti L, Guerra-Yi M, Chapuis F, Mazuir M and Curado MP: Oral cavity cancer in developed and in developing countries: Population-based incidence. Head & Neck 32(3): 357-367, 2009.
2. Ariyawardana A and Warnakulasuriya S: Declining oral cancer in Sri Lanka: Are we winning the war after heading the cancer league table? Oral Dis 17(7): 636-641. doi: 10.1111/j.1601-0825.2011.01809.x. Epub 2011 Jul 18, 2011.
3. Rogers SN, Brown JS, Woolgar JA et al: Survival following primary surgery for oral cancer. Oral Oncol 45(3): 201-211, 2009.
4. Warnakulasuriya S: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4-5): 309-316, 2009.
5. IARC: Betel-quid and areca nut chewing and some areca-nut derived nitrosamines. IARC Monographs, International Agency for Research on Cancer, 2004.
6. Warnakulasuriya S, Johnson NW and Van Der Waal I: Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36(10): 575-580, 2007.
7. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC and Mehta FS: Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 13(6): 340-341, 1985.
8. Kerr AR, Warnakulasuriya S, Mighell AJ et al: A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis 17(Suppl 1): 42-57, 2011
9. Baudis M: Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta analysis of chromosomal CGH data. BMC Cancer 7: 226, 2007.
10. Höglund M, Gisselsson D, Mandahl N et al: Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genes Chromosomes Cancer 31: 156-171, 2001.
11. Shingaki S, Takada M, Sasai K et al:. Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 185: 278-284, 2003.
12. Hermsen M, Joenje H, Arwert F et al: Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation. Oral Oncol 33: 414-418, 1997.
13. Ita M, Oga A, Hayatsu Y et al: The relationship of genetic aberrations detected by comparative genomic hybridization to DNA ploidy and tumor size in human oral squamous cell carcinomas. J Oral Pathol Med 29: 226-231, 2000.
14. Lin S-C, Chen Y-J, Kao S-Y, Hsu M-T, Lin C-H and Yang S-C: Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. Oral Oncol 38: 266-273, 2002.
15. Noutomi Y, Oga A, Uchida K et al: Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumorigenic pathways. J Pathol 210: 67-74, 2006.
16. Weber R, Scheer M, Born I et al: Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification and comparative genomic hybridization. Am J Pathol 153: 295-303, 1998.
17. Wolff E, Girod S, Liehr T et al: Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation. Oral Oncol 34: 186-190, 1998.
18. Martin CL, Reshmi SC, Ried T et al: Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol 44(4): 369-382, 2008.
19. Patmore H, Cawkwell L, Stafford N and Greenman J: Unraveling the Chromosomal Aberrations of Head and Neck Squamous Cell Carcinoma: A Review. Annals of Surgical Oncology 12(10): 831-842, 2005.
20. Roman E, Meza-Zepeda L, Kresse S, Myklebost O, Vasstrand EN and Ibrahim SO: Chromosomal abberations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. Oncol Rep 20: 825-843, 2008.
21. Scully C and Bagan J: Oral squamous cell carcinoma overview. Oral Oncology 45(4-5): 301-308, 2009.
22. Cawson RA and Eveson JW: Oral pathology and diagnosis. William Heinemann Medical Books: London, United Kingdom, 1987.
23. Pindborg JJ and Sirsat SM: Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 22(6): 764-779, 1966.
24. Meza-Zepeda LA, Kresse SH, Barragan-Polania AH et al: Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res 66(18): 8984-8993, 2006.
25. Wang J, Meza-Zepeda LA, Kresse SH and Myklebost O. M-CGH: analysing microarray-based CGH experiments. BMC Bioinformatics 5: 74, 2004.
26. Costea DE, Loro LL, Dimba EAO, Vintermyr OK and Johannessen AC: Crucial effects of fibroblasts and keratinocyte growth factor on morphogenesis of reconstituted human oral epithelium. J Invest Dermatol 121(6): 1479-1486, 2003.
27. Dysvik B, Vasstrand EN, Løvlie R et al: Gene expression profiles of head and neck carcinomas from Sudanese and Norwegian patients reveal common biological pathways regardless of race and lifestyle. Clin Cancer Res 12(4): 1109-1120, 2006.
28. Sapkota D, Bruland O, Costea DE, Haugen H, Vasstrand EN and Ibrahim SO: S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9. European Journal of Cancer 47(4): 600-610, 2011. doi: 10.1016/j.ejca.2010.10.012. Epub 2010 Nov 10, 2011
29. Lunde MLS, Warnakulasuriya S, Sand L, Hirsch JM, Vasstrand EN and Ibrahim SO: Gene expression analysis by cDNA microarray in oral cancers from two Western populations. Anticancer Res 30(4): 1083-1091, 2010.
30. Suhr ML, Dysvik B, Bruland O et al: Gene expression profile of oral squamous cell carcinomas from Sri Lankan betel quid users. Oncol Rep 18(5): 1061-1075, 2007.
31. Scully C, Field JK and Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncology 36(4): 311-327, 2000.
32. Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G and Gorgoulis VG: Advances in the biology of oral cancer. Oral Oncol 43(6): 523-534, 2007.
33. Normanno N, DE luca A, Bianco C et al: Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366(1): 2-16, 2006.
34. Caponigro F, Milano A, Ottaiano A and Iaffaioli RV: Epidermal growth factor receptor as a major anticancer drug target. Expert Opin Ther Targets 10(6): 877-888, 2006.
35. Ibrahim SO, Aarsaether N, Holsve MK et al: Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway. Oral Oncol 39(1): 37-48, 2003.
36. Sapkota D, Bruland O, Bøe OE et al: Expression profile of the S100 gene family members in oral squamous cell carcinomas. Journal of Oral Pathology & Medicine 37(10): 607-615, 2008.
37. Pietas A, Schlüns K, Marenholz I, Schäfer BW, Heizmann CW and Petersen I: Molecular Cloning and Characterization of the Human S100A14 Gene Encoding a Novel Member of the S100 Family. Genomics 79(4): 513-522, 2002.
38. JI J, Zhao L, Wang X et al: Differential expression of S100 gene family in human esophageal squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology 130(8): 480-486, 2004.
39. Sapkota D, Costea D, Blø M et al: S100A14 induces G1-arrest through nuclear accumulation of p53 and p53-dependent up-regulation of p21 in oral carcinoma derived cells. Oral Oncol 48(3): 219-225, 2012. doi: 10.1016/j.oraloncology.2011.10.001. Epub 2011 Oct 26.42, 2012.
40. Chen H, Yu D, Luo A et al: Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma. Cancer Res 69(8): 3451-3457, 2009.
41. Goh AM, Coffill CR and Lane DP: The role of mutant p53 in human cancer. J pathol 223(2): 116-26. doi: 10.1002/path.2784. Epub 2010 Oct 25, 2011.
42. Hecht SS: Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews 3(October), 2003.
43. Ibrahim SO, Vasstrand EN et al: Mutations of the p53 gene in oral squamous-cell carcinomas from Sudanese dippers of nitrosamine-rich toombak and non-snuff-dippers from the Sudan and Scandinavia. Int J Cancer 81(4): 527-534, 1999.
44. Chiba I, Muthumala M, Yamazaki Y et al: Characteristics of mutations in the p53 gene of oral squamous-cell carcinomas associated with betel-quid chewing in Sri Lanka. Int J Cancer 77(6): 839-842, 1998.
45. Ralhan R, Agarwal S, Nath N, Mathur M, Wasylyk B and Srivastava A: Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population. Oral Oncol 37(3): 243-250, 2001.
46. Warnakulasuriya KA and Ralhan R: Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco - a review. J Oral Pathol Med 36(2): 63-77, 2007.
47. Raju B, Mehrotra R, Oijordsbakken G, Al-sharabi AK, Vasstrand EN and Ibrahim SO: Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters. Anticancer Res 25(6C): 4699-4706, 2007.
48. Chidlow JR J and Sessa W: Caveolae, caveolins and cavins: complex control of cellular signalling and inflammation. Cardiovascular Res 86: 219-225, 2010.
49. Cohen AW, Hnasko R, Schubert W and LisantI MP: Role of caveolae and caveolins in health and disease. Physiol Rev 84(4): 1341-1379, 2004.
50. Engelman JA, Zhang X, Galbiati F et al: Molecular Genetics of the Caveolin Gene Family: Implications for Human Cancers, Diabetes, Alzheimer Disease, and Muscular Dystrophy. AmJHumGenet 63: 1578-1587, 1998.
51. Ando T, Ishiguro H, Kimura M et al: The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol Rep 18(3): 601-609, 2007.
52. Bau DT, Tsai MH, Tsou YA et al: The association of Caveolin-1 genotypes with oral cancer susceptibility in Taiwan. Ann Surg Oncol 18(5): 1431-8, 2011.
53. Ibrahim S, Miron T, Krohn M, Amaratunga A, Warnakulasuriya S and Vasstrand E: Tumour-associated Proteins in Oral Squamous Cell Carcinomas by Proteomics. Cancer Genomics Proteomics 2: 353-364, 2005.
54. Pennica D, Swanson TA, Welsh JW et al: WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 95(25): 14717-14722, 1998.
55. Hornstein I, Alcover A and Katzav S: Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 16(1): 1-11, 2004.
56. Fischer C, Mazzone M, Jonckx B and Carmeliet P: FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 8(12): 942-956, 2008.
57. Lyons AJ and Jones J: Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma. Int J Oral Maxillofac Surg 36(8): 671-679, 2007.
58. Kalembeyi I, Inada H, Nishiura R, Imanaka-Yoshida K, Sakakura T and Yoshida T: Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int J Cancer 105(1): 53-60, 2003.
59. Bello IO, Soini Y and Salo T: Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II). Oral Oncol 46(9): 636-643, 2010.
60. Moon C, Chae YK and LEE J: Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab. Exp Biol Med (Maywood) 235(8): 907-920, 2010.
61. Chen IH, Chang JT, Liao CT, Wang HM, Hsieh LL and Cheng AJ: Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer 89(4): 681-686, 2003.